Veratramine ameliorates pain symptoms in rats with diabetic peripheral neuropathy by inhibiting activation of the SIGMAR1-NMDAR pathway.

Pharm Biol · 2022 · PMC9665081 · PMID 36373991

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp < 0.01actually significant

Veratramine increased the pain threshold to 17.96 ± 2.57 g compared with 7.57 ± 1.87 g in the model group, a highly significant difference between the two groups ( p < 0.01, Figure 1(D) ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.